Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

NCT04329572 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
SUSPENDED
Status
400
Enrollment
INDUSTRY
Sponsor class

Stopped Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this study.

Conditions

Interventions

Sponsor

Azidus Brasil